Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02098343
Title	p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246
Recruitment	Completed
Gender	female
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Aprea Therapeutics AB
Indications	ovarian carcinoma
Therapies	Carboplatin + Doxorubicin APR-246 + Carboplatin + Doxorubicin
Age Groups:	adult \| senior
Covered Countries	USA \| NLD \| GBR \| FRA \| ESP \| DEU \| BEL